The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Chique that Frenchmans claims remind me of the items that hold the oars in place on the side of rowing boats, Rollocks.
The one question I would ask about AVA6000 if it is working(let's all hope it is) I am surprised that there has not been a leak either from a Doctor or Nurse after seeing improvement in patients or the families of a patient taking part in the trials seeing an improvement in their relative. I am overly invested in this share and have a very personal interest as a very close relative has just currently started Chemo treatment. My question is really would they be able to keep the trial information very very quiet?
I would just like to point out this prediction is made without any use of any type of chart. Here we go, I am excited and feel a bit Nostradamus, the share price will hang about at its current levels or may drop, or if there is a positive RNS it will fly up. See if I am wrong, have not allowed or made any provision for any LEAKS though.
Here ends the lesson and I hope everyone has learnt something!!!!
Thank you for you're reply Bella, I think if the theory that the chemo drugs only activate when they reach a solid tumour containing FAP cells would reduce side effects. But just wanted other opinions.
Could anyone answer this question, would the use of AVA6000 reduce the side effects of chemopherapy? For example after first dose the tingling of fingers and having a reaction too anything cold both drinking cold fluids and being adverse to opening and touching anything in the fridge/freezer., especially the first few days after treatments.
Last word says a lot, THEORY. I cannot see how this applies to any business that has a very short history and is attempting ground breaking work. I can see it applying to a FTSE 100 company, but not Avacta. One piece of news be it good or bad(hopefully good) and you can chuck the charts out of the window.
I think this poster should have been put on a RNS yesterday morning, why should a few people in America have a heads up? If it's worthy now and could affect the share price surely it should have been released to the wider world.
I think the motley fools and many others are missing the main point of AVA6000, this is not a new drug, far from it this add on only attacks the FAP protein in cancer cells and therfore will not take ten years to get to market.
Richard it's called ramping, I really enjoy the input and knowledge passed on by a number of Posters on this board, Poirot is one ver good example. But there is a lot of dross written by desparados its as if we are in a junior playground at times.
"Potential takeover" SP rises very nicely over a very good week and everyone wants the money now or even yesterday, I have been reading the same boring dross for over a year but not from this Jan/ Feb when the price collapsed. This takeover talk is not only just boring it is also extreme ramping. It's like Deja vu, just let the company continue there work and hopefully one day in the not too distant future we will reap rewards and just as important Avacta will help to save lives. Good luck to all long term holders.
Big Al has taken the moral high ground and announced that Avactas test does not pick up the lower viral loads as well as the other Covid variants, thus leading to a collapse in the share price. The other manufacturers have said not a word and probably do not care about anything than making money however ethically wrong that maybe. The hope we have is that Big Als honesty and having taken a honest and professional approach to his test will be rewarded down the line maybe with the Covid test but more likely and hopefully with AVA6000 and the other list of drugs in the pipeline But I have learnt over a period of years honesty does not always pay. GLA.